Sumitomo Dainippon Aims at 100 Billion Yen Sales from “Frontier Business,” Making Challenge Beyond Drugs

A growing number of drug makers are attempting to diversify their businesses by expanding into non-pharmaceutical sectors. Sumitomo Dainippon Pharma, which is one of these companies, aims to establish its “frontier business” as a growth engine of its midterm business...read more